Matches in Wikidata for { <http://www.wikidata.org/entity/Q95847935> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q95847935 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q95847935 description "scientific article published on 23 May 2020" @default.
- Q95847935 description "wetenschappelijk artikel" @default.
- Q95847935 description "наукова стаття, опублікована 23 травня 2020" @default.
- Q95847935 name "Chemotherapy directly followed by PARP inhibition as an alternative to surgery in patients with BRCA- mutated ovarian cancer - a potential management strategy in the era of COVID-19" @default.
- Q95847935 name "Chemotherapy directly followed by PARP inhibition as an alternative to surgery in patients with BRCA- mutated ovarian cancer - a potential management strategy in the era of COVID-19" @default.
- Q95847935 type Item @default.
- Q95847935 label "Chemotherapy directly followed by PARP inhibition as an alternative to surgery in patients with BRCA- mutated ovarian cancer - a potential management strategy in the era of COVID-19" @default.
- Q95847935 label "Chemotherapy directly followed by PARP inhibition as an alternative to surgery in patients with BRCA- mutated ovarian cancer - a potential management strategy in the era of COVID-19" @default.
- Q95847935 prefLabel "Chemotherapy directly followed by PARP inhibition as an alternative to surgery in patients with BRCA- mutated ovarian cancer - a potential management strategy in the era of COVID-19" @default.
- Q95847935 prefLabel "Chemotherapy directly followed by PARP inhibition as an alternative to surgery in patients with BRCA- mutated ovarian cancer - a potential management strategy in the era of COVID-19" @default.
- Q95847935 P1433 Q95847935-E1244A81-B3F4-4315-867E-68BDE4256A6F @default.
- Q95847935 P1476 Q95847935-37EFA23E-F087-4BA1-B864-26ECACEC0CB8 @default.
- Q95847935 P2093 Q95847935-1104D5CE-CB2A-4E96-BE2D-09D86D0C6489 @default.
- Q95847935 P2093 Q95847935-2B779A16-694B-4FE5-81A4-AD5D3F0CEA5D @default.
- Q95847935 P2093 Q95847935-A8FA6691-01C6-44FC-BA3F-CD36115603C5 @default.
- Q95847935 P2093 Q95847935-FED1311F-B8FD-4274-987E-7B4946F9B6FA @default.
- Q95847935 P2860 Q95847935-2208AFD9-B709-4461-B59B-43A67DB3CF51 @default.
- Q95847935 P2860 Q95847935-7A83A260-0A7E-495F-A185-416DB5608A53 @default.
- Q95847935 P2860 Q95847935-848A5933-3133-4211-8643-DC3394C2DBEB @default.
- Q95847935 P2860 Q95847935-FE219073-2A3B-4661-A81E-00645262BA29 @default.
- Q95847935 P31 Q95847935-FA6CCBCA-3ADD-4DFC-AB35-4B5F3ED49631 @default.
- Q95847935 P356 Q95847935-0B9ED693-A19A-4CBD-8AE3-0C52E8DE6888 @default.
- Q95847935 P577 Q95847935-630E233F-990B-4123-9FA2-2D58AA13C35C @default.
- Q95847935 P698 Q95847935-1C06738F-24E6-41D2-8042-A462BF58B174 @default.
- Q95847935 P921 Q95847935-84621BCE-1F7B-4419-862E-42D3C7A34B1E @default.
- Q95847935 P921 Q95847935-B2D8A77E-8F59-40A9-BE3B-2333A12206C8 @default.
- Q95847935 P932 Q95847935-20B62683-AF53-4116-89EB-260569B32D12 @default.
- Q95847935 P356 J.AJOG.2020.05.037 @default.
- Q95847935 P698 32454030 @default.
- Q95847935 P1433 Q4744256 @default.
- Q95847935 P1476 "Chemotherapy directly followed by PARP inhibition as an alternative to surgery in patients with BRCA- mutated ovarian cancer - a potential management strategy in the era of COVID-19" @default.
- Q95847935 P2093 "David E Cohn" @default.
- Q95847935 P2093 "Larry J Copeland" @default.
- Q95847935 P2093 "Monica Hagan Vetter" @default.
- Q95847935 P2093 "Stacy A Smrz" @default.
- Q95847935 P2860 Q38939621 @default.
- Q95847935 P2860 Q39902180 @default.
- Q95847935 P2860 Q57806929 @default.
- Q95847935 P2860 Q89746683 @default.
- Q95847935 P31 Q13442814 @default.
- Q95847935 P356 "10.1016/J.AJOG.2020.05.037" @default.
- Q95847935 P577 "2020-05-23T00:00:00Z" @default.
- Q95847935 P698 "32454030" @default.
- Q95847935 P921 Q172341 @default.
- Q95847935 P921 Q84263196 @default.
- Q95847935 P932 "7255324" @default.